JOSEPH MICHAEL RUGGIO, MD

ORANGE, CA

Research Active
Internal Medicine - Cardiovascular Disease NPI registered 21+ years 4 publications 1985 – 1996 NPI: 1124023163
MedicineCardiologyAnemia, Hemolytic, AutoimmuneHypothermia, InducedPotassiumCost ControlAnesthesia, GeneralManaged Care ProgramsLos AngelesPostoperative CareHeart Arrest, InducedMouthSpecializationMyocardial RevascularizationEconomics, Medical

Practice Location

101 THE CITY DR S
ORANGE, CA 92868-3201

Phone: (714) 456-8888

What does JOSEPH RUGGIO research?

Dr. Ruggio studies various aspects of cardiac health, particularly how to manage heart rhythm disorders and improve surgical outcomes for patients with specific needs. He has explored innovative surgery techniques that avoid traditional risks associated with certain diseases, such as cold agglutinin disease, and has researched the effects of certain medications, like beta-blockers, on patients recovering from heart attacks. By focusing on the intersection of patient care and evolving medical practices, Dr. Ruggio aims to enhance treatment strategies to ensure safer and more effective heart care.

Key findings

  • Using new guidelines for radiofrequency ablation in heart rhythm treatment reduced costs from $26,448 to $21,166 over 14 months.
  • A new heart surgery technique using warm blood for patients with cold agglutinin disease resulted in a smooth recovery, with the patient remaining healthy for over two years.
  • Patients who took beta-blockers after a heart attack had a 25% lower risk of dying from heart problems compared to those who did not, especially benefiting older patients or those with complications.

Frequently asked questions

Does Dr. Ruggio study heart rhythm disorders?
Yes, Dr. Ruggio focuses on heart rhythm disorders and how to effectively treat them, including the use of radiofrequency ablation.
What treatments has Dr. Ruggio researched?
He has researched innovative surgical techniques for heart procedures and the use of beta-blockers for recovery after heart attacks.
Is Dr. Ruggio's work relevant to patients with heart conditions?
Yes, his research directly benefits patients with heart disease, particularly those facing complex conditions like cold agglutinin disease or recovering from heart attacks.

Publications in plain English

Specialty care at the crossroads: electrophysiology practice in the managed-care era.

1996

Progress in cardiovascular diseases

Cannom DS, Ruggio J

Plain English
This study looked at how electrophysiologists, doctors who specialize in heart rhythm issues, can adapt to the changing healthcare environment where there are many specialists competing for patients. It found that using specific guidelines for a procedure called radiofrequency ablation can save money: treating patients with hard-to-manage heart rhythms cost $21,166 using the new guidelines, compared to $26,448 with traditional medical treatments over a period of 14 months. These findings are important because they highlight how effective coordination and guidelines can lead to better patient care at a lower cost in a challenging healthcare system. Who this helps: This helps patients with heart rhythm disorders and their healthcare providers.

PubMed

Cardiac operation without hypothermia for the patient with cold agglutinin.

1993

Chest

Aoki A, Kay GL, Zubiate P, Ruggio J, Kay JH

Plain English
This study focused on a new heart surgery technique that avoids using cold temperatures, which can be harmful to certain patients with a condition called cold agglutinin disease. The researchers treated one patient with this method, using warm blood and high potassium levels to protect the heart during surgery, and the patient had a smooth recovery and has stayed healthy for over two years. This matters because it shows that effective heart surgery can be done safely without the risks associated with hypothermia for patients with specific conditions. Who this helps: Patients with cold agglutinin disease needing heart surgery.

PubMed

Mouth-to-mouth resuscitation--is there a safe, effective alternative?

1987

The American journal of nursing

Birdsall C, Ruggio J

PubMed

Use of beta-adrenergic blocking agents after myocardial infarction.

1985

Postgraduate medicine

Frishman WH, Ruggio J, Furberg C

Plain English
This study looked at how beta-blockers, a type of medication, help people recover after a heart attack. The research found that patients who took beta-blockers had a 25% lower risk of dying from heart problems compared to those who did not take the medication, especially in older patients or those with complications. This is important because it shows that starting beta-blocker treatment early after a heart attack can significantly improve survival rates. Who this helps: Patients who have had a heart attack.

PubMed

Frequent Co-Authors

D S Cannom A Aoki G L Kay P Zubiate J H Kay C Birdsall W H Frishman C Furberg

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.